Cheating death can cost US$200,000 as cancer tops pharma sales
High prices force doctors to question if the benefit is worth the cost while selecting the best treatment for individual patients
Berlin
YEARS before becoming a top cancer specialist, Eric Winer used to save money on his own medical care by talking US pharmacists into giving him expired treatments for free.
Dr Winer, who has a bleeding disorder known as haemophilia, knew that the drugs would still work for a brief time after the official use-by date. The young physician was trying to stay within his insurer's spending limit and avoid having to pay out of pocket one day. Decades later, he recollected that anxious time as he tried to make sense of the soaring prices of drugs for his own cancer patients.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties
New weight-loss, diabetes drugs reach one in eight Americans
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife says private placement is to address urgent cash needs
Cordlife substantial shareholders lay out separate plans to address issues after AGM
Disney, Warner Bros Discovery launch US streaming bundle